Commentary on Freidlin and Korn

Food and Drug Administration. Establishment and operation of clinical trial data monitoring committees. Rockville, MD: US Food and Drug Agency, Center for Biologics Research, Center for Drug Evaluation Research and Center for Devices and Radiological Health, 2006.

Pocock SJ . When (not) to stop a clinical trial for benefit. J Am Med Assoc 2005; 294: 2228–2230.

Borghaei H Par-Ares L Horn L et al . Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl J Med 2015; 373: 1627–1639.

Harrington DP Fleming TR . A class of rank test procedures for censored survival data. Biometrika 1982; 69: 553–566.

Müller HH Schäfer H . Adaptive group sequential designs for clinical trials: combining the advantages of adaptive and classical group sequential approaches. Biometrics 2001; 57: 886–891.

Irle S Schäfer H . Interim design modifications in time-to-event studies. J Am Stat Assoc 2012; 107: 341–348.

Jennison C Turnbull BW . Interim analyses: the repeated confidence interval approach (with discussion). J R Stat Soc Ser B 1989; 51: 305–361.

Tsiatis AA Rosner GL Mehta CR . Exact confidence intervals following a group sequential test. Biometrics. 1984; 40: 797–803.

Mehta CR Bauer P Posch M et al . Repeated confidence intervals for adaptive group sequential trials. Stat Med 2007; 26: 5422–5433.

Brannath W Mehta CR Posch M . Exact confidence bounds following adaptive group sequential tests. Biometrics 2009; 65: 539–546.

Gao P Liu L Mehta C . Exact inference for adaptive group sequential designs. Stat Med 2013; 32: 3391–4005.

Food and Drug Administration. Draft guidance for industry adaptive design clinical trials for drugs and biologics. Rockville, MD: US Food and Drug Agency, Center for Drug Evaluation Research and Center for Biologics Research, 2010.

Mehta C Liu L . An objective re-evaluation of adaptive sample size re-estimation: commentary on “Twenty-five years of confirmatory adaptive designs.” Stat Med 2016; 35: 350–358.

Liu L Hsiao S Mehta CR . Efficiency considerations for group sequential designs with adaptive unblinded sample size re-assessment. Stat Biosci. Epub ahead of print 15 March 2017. DOI: 10.1007/s12561-017-9188-x.